PROVIDENCE – Corum Medical Inc., a medical device startup based in Providence and Sudbury, Mass., has signed a license agreement with Brown University and Rhode Island Hospital that gives Corum Medical the exclusive worldwide rights of a new noninvasive method of measuring hemoglobin.
Doctors measure levels of hemoglobin, an oxygen-transporting protein in the blood stream, to diagnose and monitor anemia. Current methods of measuring hemoglobin involve drawing blood.
Beyond Cash Donations: How New Forms of Giving Are Transforming Not-for-Profit Accounting
Evolving Funding Landscape for Not-for-Profits Not-for-profit organizations are being asked to do more with less,…
Learn More
But researchers at Brown and Rhode Island Hospital came up with a hand-held device that gauges the color of the conjunctival tissue, under a patient’s eyelid, to detect anemia.
The method will improve the efficiency of diagnosis and monitoring and the quality of patient care in various settings, from doctors’ offices to hospitals to home care, said Alan R. Kivnik, president and CEO of Corum Medical.
